These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31765060)

  • 21. A novel pathway for MuSK to induce key genes in neuromuscular synapse formation.
    Lacazette E; Le Calvez S; Gajendran N; Brenner HR
    J Cell Biol; 2003 May; 161(4):727-36. PubMed ID: 12756238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental consequences of the ColQ/MuSK interactions.
    Karmouch J; Dobbertin A; Sigoillot S; Legay C
    Chem Biol Interact; 2013 Mar; 203(1):287-91. PubMed ID: 23089045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling.
    Otsuka K; Ito M; Ohkawara B; Masuda A; Kawakami Y; Sahashi K; Nishida H; Mabuchi N; Takano A; Engel AG; Ohno K
    Sci Rep; 2015 Sep; 5():13928. PubMed ID: 26355076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Casein kinase 2-dependent serine phosphorylation of MuSK regulates acetylcholine receptor aggregation at the neuromuscular junction.
    Cheusova T; Khan MA; Schubert SW; Gavin AC; Buchou T; Jacob G; Sticht H; Allende J; Boldyreff B; Brenner HR; Hashemolhosseini S
    Genes Dev; 2006 Jul; 20(13):1800-16. PubMed ID: 16818610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK).
    Zhang W; Coldefy AS; Hubbard SR; Burden SJ
    J Biol Chem; 2011 Nov; 286(47):40624-30. PubMed ID: 21969364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity.
    Punga AR; Maj M; Lin S; Meinen S; Rüegg MA
    Eur J Neurosci; 2011 Mar; 33(5):890-8. PubMed ID: 21255125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapsyn carboxyl terminal domains mediate muscle specific kinase-induced phosphorylation of the muscle acetylcholine receptor.
    Lee Y; Rudell J; Yechikhov S; Taylor R; Swope S; Ferns M
    Neuroscience; 2008 Jun; 153(4):997-1007. PubMed ID: 18436384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital myasthenic syndromes and the formation of the neuromuscular junction.
    Beeson D; Webster R; Cossins J; Lashley D; Spearman H; Maxwell S; Slater CR; Newsom-Davis J; Palace J; Vincent A
    Ann N Y Acad Sci; 2008; 1132():99-103. PubMed ID: 18567858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.
    Tezuka T; Inoue A; Hoshi T; Weatherbee SD; Burgess RW; Ueta R; Yamanashi Y
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16556-61. PubMed ID: 25368159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signaling complexes for postsynaptic differentiation.
    Luo Z; Wang Q; Dobbins GC; Levy S; Xiong WC; Mei L
    J Neurocytol; 2003; 32(5-8):697-708. PubMed ID: 15034262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital myasthenic syndromes with acetylcholinesterase deficiency, the pathophysiological mechanisms.
    Legay C
    Ann N Y Acad Sci; 2018 Feb; 1413(1):104-110. PubMed ID: 29405353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards the molecular elucidation of congenital myasthenic syndromes: identification of mutations in MuSK.
    Chevessier F; Faraut B; Ravel-Chapuis A; Richard P; Gaudon K; Bauché S; Prioleau C; Herbst R; Goillot E; Ioos C; Azulay JP; Attarian S; Leroy JP; Fournier E; Legay C; Schaeffer L; Koenig J; Fardeau M; Eymard B; Pouget J; Hantaï D
    Acta Myol; 2005 Oct; 24(2):55-9. PubMed ID: 16550915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The severity of MUSK pathogenic variants is predicted by the protein domain they disrupt.
    Cocanougher BT; Liu SW; Francescatto L; Behura A; Anneling M; Jackson DG; Deak KL; Hornik CD; ElMallah MK; Pizoli CE; Smith EC; Tan KGQ; McDonald MT
    HGG Adv; 2024 Jul; 5(3):100288. PubMed ID: 38566418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
    Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A
    Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The muscle protein Dok-7 is essential for neuromuscular synaptogenesis.
    Okada K; Inoue A; Okada M; Murata Y; Kakuta S; Jigami T; Kubo S; Shiraishi H; Eguchi K; Motomura M; Akiyama T; Iwakura Y; Higuchi O; Yamanashi Y
    Science; 2006 Jun; 312(5781):1802-5. PubMed ID: 16794080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinase domain of the muscle-specific receptor tyrosine kinase (MuSK) is sufficient for phosphorylation but not clustering of acetylcholine receptors: required role for the MuSK ectodomain?
    Glass DJ; Apel ED; Shah S; Bowen DC; DeChiara TM; Stitt TN; Sanes JR; Yancopoulos GD
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8848-53. PubMed ID: 9238066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital myasthenic syndrome from a
    McLean A; Wilson I
    Pract Neurol; 2024 May; 24(3):238-240. PubMed ID: 37985124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
    Cossins J; Liu WW; Belaya K; Maxwell S; Oldridge M; Lester T; Robb S; Beeson D
    Hum Mol Genet; 2012 Sep; 21(17):3765-75. PubMed ID: 22661499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations.
    Rodríguez Cruz PM; Cossins J; Estephan EP; Munell F; Selby K; Hirano M; Maroofin R; Mehrjardi MYV; Chow G; Carr A; Manzur A; Robb S; Munot P; Wei Liu W; Banka S; Fraser H; De Goede C; Zanoteli E; Conti Reed U; Sage A; Gratacos M; Macaya A; Dusl M; Senderek J; Töpf A; Hofer M; Knight R; Ramdas S; Jayawant S; Lochmüller H; Palace J; Beeson D
    Brain; 2019 Jun; 142(6):1547-1560. PubMed ID: 31081514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A class of chemical compounds enhances clustering of muscle nicotinic acetylcholine receptor in cultured myogenic cells.
    Miyairi Y; Ohkawara B; Sato A; Sawada R; Ishii H; Tomita H; Inoue T; Nakashima H; Ito M; Masuda A; Hosono Y; Imagama S; Ohno K
    Biochem Biophys Res Commun; 2024 Oct; 731():150400. PubMed ID: 39024975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.